3D-FACS: 3D image-based fluorescence activated cell sorting
Award amount
$1,491,613Program and phase
SBIR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NANOCELLECT BIOMEDICAL INC
- Proposal award date
- 2019-09-15
- Contract end date
- 2021-08-31
- UEI
- MSN6LQLSWWJ8
- Solicitation number
- PA18-574
- Topic code
- NIDA
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
- 3D Imaging Flow Cytometer
- High-throughput single-cell sorting and kinetic analysis of secreted particles
- iFACS: Imaging Florescence Activated Cell Sorter to sort cells based on images
- Imaging Flow Cytometry Enabled by a Spatial-Frequency Filter
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
16 SBIR/STTR records share this UEI (2010–2022). Reported award amounts total $13,057,867. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services